Clinicians stay connected with tools that offer real-time data, including personal digital assistants, patient care robots, network voice communication badges, and telehealth. Using this technology, clinicians will soon be able to access the patient's entire electronic health record at the point of care. Although the hardware and the software are evolving, many solutions are currently available.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/00006205-200404000-00008 | DOI Listing |
Disabil Rehabil Assist Technol
January 2025
School of Health and Rehabilitation Sciences, The Ohio State University, Columbus, Ohio, USA.
The wheelchair service delivery process (SDP) is a large complex system and therefore has many potential points of failure; determining priorities for improvement is challenging. The complexities introduce several barriers to accessing and maintaining wheelchairs for individuals with mobility impairments. Given the breadth and depth of the barriers, it is important to know in which areas to focus future policy reform efforts.
View Article and Find Full Text PDFJ Clin Med
December 2024
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité, 13353 Berlin, Germany.
The HeartMate 3 (HM3, Abbott) left ventricular assist device (LVAD) is the only commercially available option considered suitable for long-term circulatory support. External compression of the outflow graft causing obstruction (eOGO) is a serious adverse event affecting patients on long-term support. The obstruction occurs due to the accumulation of gelatinous substance between the bend relief and outflow graft.
View Article and Find Full Text PDFJ Clin Med
December 2024
Faculty of Medicine, Wroclaw University of Science and Technology, 50-370 Wroclaw, Poland.
BMC Cancer
January 2025
Department of Pharmacy, Hainan Cancer Hospital, Haikou, Hainan, China.
Background: To identify the factors influencing pyrotinib-induced severe diarrhea and to establish a risk prediction nomogram model.
Methods: The clinical data of 226 patients received pyrotinib from two medical institutions from January 2019 to December 2023 were analysed retrospectively. A training set was made up of 167 patients from Hainan Cancer Hospital, and the external validation set was made up of 59 patients from Hainan West Central Hospital.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!